ASX:BOT
ASX:BOTPharmaceuticals

Will Botanix Pharmaceuticals’ (ASX:BOT) Investor Outreach Reinforce Management Credibility or Raise Fresh Questions?

Botanix Pharmaceuticals recently held a special call to update investors on its quarterly activity report and Sofdra® topical gel launch, and is set to present at the 2025 Canaccord Genuity Drug & Device Conference with CEO Howie McKibbon as speaker. These events highlight the company's efforts to communicate operational progress and product momentum to the market at key industry forums. We’ll explore how management’s proactive communication on the Sofdra launch is shaping Botanix...
ASX:VEA
ASX:VEAOil and Gas

Should Weak Q3 Sales and Refining Intake Prompt Action From Viva Energy (ASX:VEA) Investors?

Viva Energy Group recently reported a decrease in third-quarter convenience sales to A$392 million and a 23% drop in refining intake, primarily due to maintenance activities. This update also highlighted the impact of regulatory changes on tobacco sales and rising in-store wage costs affecting the company’s operations. We'll examine how weaker convenience sales amid regulatory pressures could influence Viva Energy Group’s investment case moving forward. Find companies with promising cash...
ASX:ELS
ASX:ELSElectronic

Elsight (ASX:ELS) Is Up 11.6% After Posting Record Revenue and First-Time Profitability

On October 29, 2025, Elsight Limited reported its Q3 2025 earnings, achieving record-breaking quarterly revenue and reaching profitability for the first time in company history. Driving this milestone was robust growth across both defense and commercial markets, supported by increased investor attention following Elsight's inclusion in major ASX indices. Let's explore how Elsight's first-time profitability and broader market visibility shape its investment narrative going forward. Explore 28...
ASX:ABY
ASX:ABYSpecialty Retail

3 ASX Penny Stocks With Market Caps Under A$800M To Consider

As the Australian market braces for the crucial consumer price index release, investors are keenly observing how this will influence the Reserve Bank's upcoming cash rate decision. In such a climate, penny stocks—though an outdated term—continue to capture interest as they often represent smaller or newer companies with unique growth potential. This article explores three compelling ASX penny stocks that stand out for their financial resilience and potential opportunities in today's market...